Alpha Centric Advisors LLC Amylyx Pharmaceuticals, Inc. Transaction History

Alpha Centric Advisors LLC

  • $118 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.07 - $18.46 $66,385 - $101,530
5,500 Added 3.78%
151,000 $2.22 Million
Q3 2023

Nov 13, 2023
BUY
$18.08 - $23.45 $677,999 - $879,375
37,500 Added 34.72%
145,500 $2.66 Million
Q2 2023

Aug 08, 2023
BUY
$20.98 - $31.42 $2.11 Million - $3.16 Million
100,500 Added 1340.0%
108,000 $2.33 Million
Q1 2023

May 12, 2023
BUY
$27.71 - $40.93 $207,825 - $306,975
7,500 New
7,500 $220,000

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $227M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email